PANAGORA ASSET MANAGEMENT INC - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 155 filers reported holding REVANCE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.20 and the average weighting 0.1%.

Quarter-by-quarter ownership
PANAGORA ASSET MANAGEMENT INC ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$958,000
+447.4%
49,123
+358.8%
0.01%
+400.0%
Q4 2021$175,000
-88.6%
10,707
-78.6%
0.00%
-83.3%
Q1 2018$1,538,000
+15280.0%
49,934
+12670.8%
0.01%
Q2 2017$10,000
-82.5%
391
-77.9%
0.00%
Q2 2015$57,000
-95.5%
1,771
-95.2%
0.00%
-100.0%
Q2 2014$1,262,000
+3.9%
37,118
-3.8%
0.01%0.0%
Q1 2014$1,215,00038,5730.01%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
Palo Alto Investors LP 4,405,039$118,936,0009.40%
Essex Woodlands Management, Inc. 457,085$12,341,0005.10%
Evolutionary Tree Capital Management, LLC 191,868$5,180,0004.98%
Ghost Tree Capital, LLC 390,000$10,530,0002.96%
Antara Capital LP 4,069,400$109,874,0002.90%
RICE HALL JAMES & ASSOCIATES, LLC 896,754$24,212,0001.40%
Jericho Capital Asset Management L.P. 714,000$19,278,0001.22%
Antara Capital LP 1,600,000$43,200,0001.14%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 120,000$3,240,0001.04%
TANG CAPITAL MANAGEMENT LLC 287,500$7,763,0000.95%
View complete list of REVANCE THERAPEUTICS INC shareholders